Table 1.
Prevalence of resistance to adamantanes among A(H3N2) viruses collected globally during the 2006–2007 influenza season (1 October 2006 through 30 September 2007)
| Geographic location | No. viruses tested | No. viruses resistant | Resistance (%) |
|---|---|---|---|
| Africa (total) | 32 | 7 | 21·9 |
| Asia (total) | 363 | 228 | 62·8 |
| China | 69 | 69 | 100 |
| Hong Kong (SAR) | 13 | 9 | 69·2 |
| Japan | 21 | 18 | 85·7 |
| Asia (other) | 159 | 76 | 47·8 |
| Europe (total) | 100 | 39 | 39·0 |
| North America (total) | 588 | 429 | 72·9 |
| Canada | 143 | 43 | 30·1 |
| Mexico | 44 | 40 | 90·9 |
| United States | 401 | 346 | 86·3 |
| South America (total) | 363 | 357 | 98·3 |
| Oceania (total) | 5 | 4 | 80·0 |
| Overall | 1451 | 1064 | 73·3 |
Data represents the number of total tested isolates compared with the number of resistant isolates. Africa: Egypt, Kenya, Madagascar, Mauritius, and Uganda; Other Asia: Bangladesh, India, Kazakhstan, Korea, Mongolia, Nepal, Taiwan, Thailand, and Vietnam; Europe: Belarus, Bulgaria, Croatia, Denmark, France, Greece, Italy, Russia, Spain, Ukraine and United Kingdom; South America: Argentina, Brazil, Chile, Costa‐Rica, Dominican Republic, El Salvador, French Guyana, Guadeloupe, Honduras, Panama, Peru, Trinidad‐Tobago, and Uruguay; Oceania: Australia and New Caledonia.